View |
|
BR-572
|
BCG Vaccine
|
None
|
None
|
Freeze-Dried Powder For Injection (I.D.)
|
Prescription Drug (RX)
|
Amber glass vial with blue flip off cap x 1mL+0.9% w/v Sodium Chloride as diluent in clear and colorless glass ampoule x 1mL (Box of 1's and 50's)
|
-
|
Serum Institute of India Ltd.
|
India
|
|
Genpharma, Inc.
|
Genpharma, Inc.
|
-
|
08 September 2020
|
17 February 2025
|
View |
|
BR-574
|
Hepatitis B vaccine (rDNA)
|
Genvac-B
|
20mcg/mL
|
Suspension For Injection (IM) Single Dose (Adult)
|
Prescription Drug (RX)
|
Glass vial x 10 mL (Box of 50's)
|
-
|
Serum Institue of India Pvt. Ltd.
|
India
|
|
Genpharm Inc.
|
Genpharm Inc.
|
-
|
13 April 2022
|
11 May 2025
|
View |
|
BR-589
|
Hepatitis B Vaccine ( rDNA)
|
None
|
10mcg/0.5mL
|
Suspension for Injection (IM) (Pediatric)
|
Prescription Drug (RX)
|
5 mL Clear Glass Vial (Box of 50's)
|
-
|
Serum Institute of India Private Limited
|
India
|
|
Genpharm, Inc.
|
|
-
|
26 February 2021
|
05 October 2025
|
View |
|
BR-591
|
Tuberculin Purified Protein Derivative
|
None
|
2TU/0.1mL
|
Solution For Injection (Id)
|
Prescription Drug (RX)
|
1ML, 1.5ML, 5ML, 10ML VIAL PER BOX
|
Diagnostic Agent
|
Arkray Healthcare Pvt. Ltd.
|
India
|
|
National Biotec Medical Supply Co., Ltd
|
L. Meyerf Pharma Inc
|
Renewal (Variation)
|
02 August 2022
|
28 October 2027
|
View |
|
BR-596
|
Bacillus Calmette-Guerin (BCG) Vaccine
|
None
|
250 mcg
|
Freeze-dried Powder for Intradermal Injection
|
Prescription Drug (RX)
|
In a box consisting of 1 plastic tray containing 0.5 mL- capacity clear and colorless glass ampoule x 5's and 1 plastic tray containing 0.5 mL-net content of Sterile Water for Injection in an ampoule x 5's
|
Immunostimulant
|
Chengdu Institute of Biological Products
|
China
|
N/A
|
National Biotec Medical Supply Co. Ltd.
|
National Biotec Medical Supply Co. Ltd.
|
Renewal
|
24 August 2023
|
10 March 2028
|
View |
|
BR-599
|
Human Tetanus Immunoglobulin
|
Tetagam P
|
250 I.U. (100 mg to 170 mg)/mL
|
Solution For Injection (I.M.)
|
Prescription Drug (RX)
|
1 mL pre-filled syringe with 1 separate safety glide
needle x 216 12" per box
|
-
|
CSL Behring GmbH
|
Germany
|
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
-
|
28 October 2021
|
12 September 2026
|
View |
|
BR-602
|
Human Papillomavirus Vaccine (Types 6, 11, 16 And 18) (Recombinant Adsorbed
|
Gardasil
|
Each 0.5 mL contains: Type 6 Ll protein 20 ug
Type 11 L1 protein 40 ug
Type 16 L1 protein 40 ug
Type 18 L1 protein 20 ug
|
Suspension for Injection IM
|
Prescription Drug (RX)
|
1.5 mL USP/EP Type I pre-filled glass syringe with green plunger rod + 2 sterile needles (23G x 1" and 25G x 1") [Box of 1's]
|
Vaccine
|
Merck Sharp & Dohme Corp.
|
United States of America
|
|
Merck Sharp & Dohme (I.A.) LLC
|
|
Renewal
|
03 October 2023
|
19 October 2028
|
View |
|
BR-603
|
Human Papillomavrius Vaccine [Types 6, 11, 16, 18] (Recombinant, Adsorbed)
|
Gardasil
|
0.5mL (See Reverse Dosage)
|
Suspension for Injection IM
|
Prescription Drug (RX)
|
3mL USP/EP Type I glass vial with grey chlorobutyl stopper nad green plastic flip-off cap and Vaccine Vial Monitor (VVM30) [Box of 1's and 10's]
|
Vaccine
|
Merck Sharp & Dohme Corp.
|
United States of America
|
|
Merck Sharp & Dohme (I.A.) Corporation
|
|
Renewal
|
30 January 2020
|
19 October 2028
|
View |
|
BR-615
|
Rotavirus Vaccine, Live
|
Rotateq
|
2mL
|
Solution For Oral Administration - Single Dose
|
Prescription Drug (RX)
|
2 mL single dose plastic dosing tube in individual foil pouch per box (Box of 1's, 10's, and 25's). Single Dose.
|
Vaccines
|
Merck Sharp & Dohme Corp
|
United States of America
|
`
|
Merck Sharp & Dohme (I.A.) LLC
|
|
Renewal
|
08 September 2024
|
02 August 2029
|
View |
|
BR-616
|
Human Papillomavirus Vaccine [Types 16, 18]
(Recombinant, Adjuvanted, Adsorbed)
|
Cervarix
|
0.5 mL
|
Suspension For Injection (I.M.)
|
Prescription Drug (RX)
|
Single dose. Type I pre-filled glass syringe with butyl
rubber plunger stopper x 0.5 mL + Sterile needle 236 x 1" (Box of 1's)
|
-
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
|
GlaxoSmithKline Philippines, Inc.
|
|
-
|
16 December 2021
|
07 September 2026
|
View |
|
BR-619
|
Tetanus Toxoid Adsorbed
|
IMATET
|
40 IU/0.5 ML
|
SUSPENSION FOR INJECTION (IM)
|
Prescription Drug (Rx)
|
USP Type I Glass Ampoule (Box of 10's)
|
VACCINE
|
AMSON VACCINES & PHARMA (PVT.) LTD.
|
Pakistan
|
N/A
|
Sahar International Trading, Inc.
|
Sahar International Trading, Inc.
|
Renewal
|
05 August 2022
|
24 August 2027
|
View |
|
BR-629
|
Purified Vero Cell Rabies Vaccine
|
Abhayrab
|
2.5 IU/0.5 mL
|
Freeze Dried Powder For Injection (I.M./I.D.)
|
Prescription Drug (RX)
|
Clear, colorless glass vial
|
Vaccine
|
Human Biologicals Institute (A Division of Indian Immunologicals Limited)
|
India
|
|
2 World Traders Inc
|
2 World Traders Inc
|
Automatic Renewal
|
22 December 2022
|
21 February 2028
|
View |
|
BR-630
|
Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed'
|
Boostrix
|
Formulation: Each dose (0.5 mL) contains:
Diphtheria toxoid -2.5LF Tetanus toxoid-5.0 Lf Pertussis toxoid-8 mcg Filamentous hemagglutinin (FHA)-8 mcg Pertactin (PRN or 69 kDa OMP)-2.5 mcg
|
0.5 mL Suspension for Injection (IM) - 2PE (See reverse for Formulation)
|
Prescription Drug (RX)
|
0.5 mL Pre-filled Type I Glass Syringe + 2 Sterile Needles [23G x 1" and 25G x 5/8"] (Box of 1's) (Single Dose)
|
-
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
|
GlaxoSmithKline Philippines, Inc.
|
|
-
|
19 February 2021
|
09 September 2025
|
View |
|
BR-632
|
Epoetin alfa (Recombinant Human Erythropoietin)
|
Epotin
|
4000 IU/ mL
|
Solution for Injection (IV/SC)
|
Prescription Drug (Rx)
|
1 mL glass vial (box of 10's)
|
Other Antianemic Preparations
|
Gulf Pharmaceuticals Industries (Julphar)
|
UAE
|
|
DéGa International Pharma Corp.
|
DéGa International Pharma Corp.
|
Automatic Renewal
|
10 August 2021
|
19 August 2026
|
View |
|
BR-637
|
Epoetin Alfa
|
Epokine
|
4000 IU/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
1 mL Clear vial (Box of 10's)
|
Anti-anaemic Preparations
|
HK inno.N Corporation
|
Korea
|
|
Macropharma Corporation
|
Macropharma Corporation
|
Automatic Renewal
|
07 January 2022
|
20 October 2026
|
View |
|
BR-638
|
Methoxy Polyethylene Glycol-Epoetin Beta
|
Mircera
|
50 mcg/0.3 mL
|
Solution for Injection (I.V./S.C.)
|
Prescription Drug (Rx)
|
0.3 mL pre-filled glass syringe + 27 ½" needle per box of 1's. Single Dose.
|
-
|
Roche Diagnostics GmbH
|
Germany
|
For: F. Hoffmann-La Roche Ltd.- Basel, Switzerland
|
Roche (Philippines), Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
18 September 2021
|
07 October 2026
|
View |
|
BR-642
|
Methoxy Polyethylene Glycol-Epoetin Beta
|
Mircera
|
200 mcg/0.3 mL
|
Solution for Injection (I.V./S.C.)
|
Prescription Drug (Rx)
|
0.3 mL pre-filled glass syringe + 27 ½" needle per box of 1's. Single Dose.
|
Erythropoiesis Stimulating Agent
|
Roche Diagnostics GmbH
|
Germany
|
For: F. Hoffmann-La Roche Ltd.- Basel, Switzerland
|
Roche (Philippines), Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
23 September 2021
|
15 September 2026
|
View |
|
BR-645
|
Epoetin Alfa
|
Epogen
|
4000 IU/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
1 mL prefilled glass syringe with red push rod and chlorobutyl rubber stopper in blister pack (Box of 1's)
|
Hematopoietic Growth Factors
|
Harbin Pharmaceutical Group Bioengineering Co.,
Ltd.
|
China
|
|
Endure Medical, Inc.
|
Endure Medical, Inc.
|
Renewal
|
20 August 2024
|
08 October 2029
|
View |
|
BR-647
|
Methoxy Polyethylene Glycol-Epoetin Beta
|
Mircera
|
100 mcg/0.3 mL
|
Solution for Injection (I.V./S.C.)
|
Prescription Drug (Rx)
|
0.3 mL pre-filled glass syringe + 27 ½" needle per box of 1's. Single Dose.
|
Erythropoiesis Stimulating Agent
|
Roche Diagnostics GmbH
|
Germany
|
For: F. Hoffmann-La Roche Ltd.- Basel, Switzerland
|
Roche (Philippines), Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
23 September 2021
|
15 September 2026
|
View |
|
BR-651
|
Human Normal Immunoglobulin
|
Ig Vena
|
50mg/mL
|
Solution For Infusion (Iv)
|
Prescription Drug (RX)
|
Clear glass vial x 20mL, 100mL and 200mL (Box of 1's)
|
Immunoglobulin
|
Kedrion S.p.A
|
Italy
|
|
New Marketlink Pharmaceuticals Coporation
|
Metro Drug Inc.
|
Renewal
|
02 November 2023
|
07 November 2028
|